AHMED ABDELAZIZ, M.D.
Hematology & Oncology Physician · TUCSON, AZ
Individual Active NPI 1477817971
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 681 | 241,352 | $10,985,004 | $2,933,295 | $2,334,442 |
| 2023 | 640 | 221,088 | $10,780,063 | $2,995,455 | $2,381,747 |
| 2022 | 677 | 216,137 | $10,650,321 | $2,989,541 | $2,378,361 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| Q5110 | Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | 27,360 | $0 | $0 |
| J9271 | Injection, pembrolizumab, 1 mg | 10,300 | $54 | $43 |
| J9267 | Injection, paclitaxel, 1 mg | 9,530 | $0 | $0 |
| J1453 | Injection, fosaprepitant, 1 mg | 8,250 | $0 | $0 |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 6,320 | $3 | $2 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 6,120 | $48 | $38 |
| J0185 | Injection, aprepitant, 1 mg | 5,200 | $2 | $1 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 2,053 | $0 | $0 |
| J1437 | Injection, ferric derisomaltose, 10 mg | 2,000 | $20 | $16 |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | 1,530 | $0 | $0 |
| J0897 | Injection, denosumab, 1 mg | 1,440 | $25 | $20 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 1,300 | $1 | $1 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | 54277 | AZ |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in Arizona
- NPI 1497070221
- NPI 1730341850
- NPI 1306285267
- NPI 1144392291
- NPI 1093370918
- NPI 1679501282
- NPI 1578976379
- NPI 1215340013
See all Hematology & Oncology Physician providers in Arizona →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.